Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
Pfizer recommends that shareholders do not tender their shares in response to Tutanota’s offer
The endorsement follows overwhelming support for the share swap preceding the merger,
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
Doctors recommended a robotic Strassmann Metroplasty, a reconstructive surgery that joins the two halves of the uterus into a single cavity capable of supporting pregnancy
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
India’s pharmaceutical sector stands at a pivotal inflection point
Subscribe To Our Newsletter & Stay Updated